References
- Sankaran VG, Xu J, Orkin SH. Advances in the understanding of haemoglobin switching. Br J Haematol. 2010;149(2):181–194. doi:10.1111/j.1365-2141.2010.08105.x
- Huang H, Xu L, Chen M, et al. Molecular characterization of thalassemia and hemoglobinopathy in southeastern China. Sci Rep. 2019;9(1):3493. doi:10.1038/s41598-019-40089-5
- Zhuang J, Jiang Y, Wang Y, et al. Molecular analysis of α-thalassemia and β-thalassemia in quanzhou region southeast China. J Clin Pathol. 2020;73(5):278–282. doi:10.1136/jclinpath-2019-206179
- Chen J, Lin S, Gan J, et al. A novel β-thalassemia variant at HBB:c.14delC (codon 4, -C) identified via next-generation sequencing. Hematology. 2020;25(1):400–404. doi:10.1080/16078454.2020.1841920
- Peng C, Zhang H, Ren J, et al. Analysis of rare thalassemia genetic variants based on third-generation sequencing. Sci Rep. 2022;12(1):9907. doi:10.1038/s41598-022-14038-8
- Xu L, Mao A, Liu H, et al. Long-Molecule sequencing. J Mol Diagn. 2020;22(8):1087–1095. doi:10.1016/j.jmoldx.2020.05.004
- Mirzakhani M, Tarrahi MJ, Baghersad A, et al. Can couples With MCV≥80, MCH<26, HbA2 < 3.2, HbF<3 be classified as Low-risk β-thalassemia group? J Pediatr Hematol Oncol. 2019;41(4):303–306. doi:10.1097/MPH.0000000000001423
- Wu Y, Yao Q, Zhong M, et al. Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China. Ann Hematol. 2020;99(12):2747–2753. doi:10.1007/s00277-020-04252-7
- Chan NCN, Wong THY, Cheng KCK, et al. An evaluation for the causes of reduced Hb A2and the molecular characterization of HBD variants in Hong Kong. Hemoglobin. 2021;45(6):387–391. doi:10.1080/03630269.2021.1965619
- Wenger AM, Peluso P, Rowell WJ, et al. Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome. Nat. Biotechnol. 2019;37:1155–1162. doi:10.1038/s41587-019-0217-9
- Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am. 2018;32:193–211. doi:10.1016/j.hoc.2017.11.006
- Chen M, Ye Y, Liao L, et al. Hereditary spherocytosis overlooked for 7 years in a pediatric patient with β-thalassemia trait and novel compound heterozygous mutations of SPTA1 gene. Adv Hematol. 2020;25(1):438–445. doi:10.1080/16078454.2020.1846874.
- Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of hemoglobin H disease in childhood. NEJM. 2011;364:710–718. doi:10.1056/NEJMoa1010174
- Sakorn P, Nur-Afsan S, Monthathip T, et al. Hematological analysis in Thai samples With deletional and nondeletional HbH diseases. Lab Med. 2018;49(2):154–159. doi:10.1093/labmed/lmx068.
- Chen P, Li SQ, Wu H. Alpha 2 codon 30 deletion (deltaGAG) causing non-deletional hemoglobin H disease in guangxi province. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21(5):435–439. doi:10.3760/j.issn:1003-9406.2004.05.005.
- Ma SK, Chan AY, Chiu EK, et al. Haemoglobin H disease due to (SEA) α-globin gene deletion and α2-codon 30 (ΔGAG) mutation: a family study. Clin Lab Haematol. 2001;23(5):325–327. doi:10.1046/j.1365-2257.2001.00411.x
- Chen X, Luo M, Pan L, et al. A novel 4.9 Kb deletion at beta-globin gene is identified by the third-generation sequencing: case report from baoan, China. Int. J. Biochem. Mol. Biol. 2022;529:10–16. doi:10.1016/j.cca.2022.01.024.